DC-CIK
Sponsors
Fuzhou General Hospital, Capital Medical University, Guangxi Medical University, Shenzhen Hornetcorn Bio-technology Company, LTD, Sixth Affiliated Hospital, Sun Yat-sen University
Conditions
Advanced Liver CancersBreast CancerColorectal CancerDigestive System NeoplasmsEsophageal CancerEsophageal NeoplasmsGastric CancerGastrointestinal Diseases
Phase 1
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma
NCT00862303
Start: 2009-03-31End: 2015-12-31Target: 100Updated: 2011-03-08
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
CompletedNCT01783951
Start: 2013-02-01End: 2018-06-01Updated: 2018-07-19
Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)
CompletedNCT02418481
Start: 2015-04-30End: 2016-06-30Updated: 2016-07-19
Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)
CompletedNCT02425748
Start: 2017-06-08End: 2019-06-20Updated: 2019-09-12
Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers
NCT05622825
Start: 2023-01-31End: 2024-12-31Target: 15Updated: 2022-11-21
Phase 2
Study of DC-CIK to Treat NPC
NCT01821495
Start: 2013-05-31End: 2018-05-31Target: 100Updated: 2013-04-12
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer
NCT02202928
Start: 2014-07-31End: 2017-12-31Target: 60Updated: 2015-12-28
DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer
NCT02415699
Start: 2015-08-31End: 2020-07-31Target: 100Updated: 2015-04-14
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
Not yet recruitingNCT02487550
Start: 2015-08-31End: 2030-07-31Target: 1200Updated: 2015-07-01
DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma
NCT02487017
Start: 2015-05-31End: 2018-12-31Target: 60Updated: 2016-05-24
Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer
NCT02644863
Start: 2015-12-31End: 2019-05-31Target: 60Updated: 2016-05-24